Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

CVS' health services division processed 484.1 million pharmacy claims during the quarter, down from 579.6 million during the ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

CVS Health Co. (NYSE:CVS – Get Free Report) reached a new 52-week low during mid-day trading on Friday after Royal Bank of Canada lowered their price target on the stock from $68.00 to $58.00. Royal ...

Harbour Investments Inc. lowered its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 5.3% in the third quarter, ...

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, ...